RNAi is One of the Areas to Watch in 2006 according to Science Magazine

Today Science magazine highlights major scientific breakthroughs for 2005. It also talks about eight major areas selected as potential breakthroughs for 2006. RNAi is one of the hot areas for the coming year. This is what Science says about RNAi-based therapies: "They're moving into human patients with startling speed, and 2006 should offer the first hints of how well the highly touted technique works. Company-funded trials in macular degeneration and the pediatric illness respiratory syncytial virus are under way; another targeting hepatitis C is supposed to launch soon, with some therapies for neurological diseases to follow. Oh, and another treatment that's coming down the pike: RNAi for permanent hair removal." Alnylam (ALNY) is one of the companies seeking to capitalize on RNAi-based drugs. Since I highlighted recent research at ALNY in Nov-05 the stock is up ~40%. But I would not be adding ALNY shares here. I think the market is ripe for some correction and will present plenty of better buying opportunities for ALNY and other Biotechs in the coming months.

Tech Tags: RNAi ALNY Alnylam antagomir Stock Investment